Find research datasets worth reusing

Fig. 7 in Deciphering the roles of leucine-rich repeat receptor-like protein kinases (LRR-RLKs) in response to Fusarium wilt in the Vernicia fordii (Tung tree)

Fig. 7. The expression patterns of two gene pairs (i.e. Vf01G2125 and Vf03G1740, and Vf06G2687 and Vf10G1659) were generated by tandem duplication events. Numbers on the x-axis indicate the following: seeds at 10, 15, 20, 25, and 30 weeks after flowering (WAF; 10_WAF, 15_WAF, 20_WAF, 25_WAF, and 30_WAF), male flowers at 30, 20, 10, and 1 days before flowering (X1-X4), female flowers at 30, 20, 10, and 1 days before flowering (C1–C4), young leaves, roots, stems, and hermaphrodite (CX).

Fig. 5 in Deciphering the roles of leucine-rich repeat receptor-like protein kinases (LRR-RLKs) in response to Fusarium wilt in the Vernicia fordii (Tung tree)

Fig. 5. Expression of VfLRR-RLK gene family members. The heat map depicts expression profiles of VfLRR-RLKs in V. fordii (left) and V. montana (right) in response to Fusarium wilt at four infection stages: 0, uninfected stage; 1, 2 days after Fusarium wilt infection (dpi); 2, 8 dpi; 3, 13 dpi. F0–F3 indicated the expression of VfLRRRLKs in V. fordii during the infection stage (0, 1, 2, 3) by the pathogen Fusarium wilt; M0-M3 indicated the expression of VfLRR-RLKs in V. montana during the infection stage (0, 1, 2, 3) by the pathogen Fusarium wilt. The innermost circle represents 0, followed by 1, 2, and the outermost circle represents 3.

Fig. 4 in Deciphering the roles of leucine-rich repeat receptor-like protein kinases (LRR-RLKs) in response to Fusarium wilt in the Vernicia fordii (Tung tree)

Fig. 4. The similar expression patterns between duplicated VfLRR-RLK gene pairs during vegetative and reproductive development. Numbers on the x-axis indicate the following: seeds at 10, 15, 20, 25, and 30 weeks after flowering (WAF; 10_WAF, 15_WAF, 20_WAF, 25_WAF, and 30_WAF), male flowers at 30, 20, 10, and 1 days before flowering (X1-X4), female flowers at 30, 20, 10, and 1 days before flowering (C1–C4), young leaves, roots, stems, and hermaphrodite (CX).

Fig. 6 in Deciphering the roles of leucine-rich repeat receptor-like protein kinases (LRR-RLKs) in response to Fusarium wilt in the Vernicia fordii (Tung tree)

Fig. 6. The qRT-PCR experiments of four VfLRR-RLKs in response to Fusarium wilt. Black represents these VfLRR-RLKs in response to Fusarium wilt in V. fordii. Grey represents these VfLRR-RLKs in response to Fusarium wilt in V. montana. The numbers in the x-axis indicate the two stages of infection, as follows: 1, uninfected stage; 2, late stage of infection.

Fig. 3 in Deciphering the roles of leucine-rich repeat receptor-like protein kinases (LRR-RLKs) in response to Fusarium wilt in the Vernicia fordii (Tung tree)

Fig. 3. Collinearity relationships of LRR-RLKs in V. fordii and the other four Euphorbiaceae genomes. The chromosomes of different Euphorbiaceae species were depicted as blocks of different colors. Gene pairs with a syntenic relationship between different Euphorbiaceae species were connected by different colored lines. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Fig. 1 in Deciphering the roles of leucine-rich repeat receptor-like protein kinases (LRR-RLKs) in response to Fusarium wilt in the Vernicia fordii (Tung tree)

Fig. 1. The maximum likelihood tree and synteny analysis among these five Euphorbiaceae genomes. All LRR-RLKs were divided into 22 groups and were distinguished by different colors. These different groups were determined and defined based on the A. thaliana homologs nomenclature within the same group (Shiu and Bleecker, 2001b). The synteny relationships between different Euphorbiaceae genomes were represented by different links. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Fig. 2 in Deciphering the roles of leucine-rich repeat receptor-like protein kinases (LRR-RLKs) in response to Fusarium wilt in the Vernicia fordii (Tung tree)

Fig. 2. The circos figures for chromosome locations with segmental duplication links in M. esculenta (Me; green), H. brasiliensis (Hb; orange), J. curcas (Jc; yellow), R. communis (Rc; blue), and V. fordii (Vf; cyan). The different lines suggested segmented duplicated gene pairs among these five Euphorbiaceae genomes. All the collinearity pairs are represented by grey background. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)

Fig. 2 in Synthesis of bilocularin A carbamate derivatives and their evaluation as leucine transport inhibitors in prostate cancer cells

Fig. 2. COSY (in green) and key HMBC (in red) correlations of compound 2. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Fig. 4 in Synthesis of bilocularin A carbamate derivatives and their evaluation as leucine transport inhibitors in prostate cancer cells

Fig. 4. Effects of compounds 1–9 on cell viability and leucine uptake in LNCaP cells (a) MTT cell growth assay was performed in LNCaP cells treated with compounds 1–9 at 20 μM for 72 h (n = 3, mean ± SEM) (b) [3H]-L-leucine uptake was performed using 20 μM of compounds 1–9 in LNCaP cells (n = 3, mean ± SEM). Asterisks represent Pvalues: *P ⩽ 0.05; ***P ⩽ 0.001 for one-way analysis of variance by Dunnett's multiple comparison test (c) [3H]-L-leucine uptake was performed at varying doses of compounds 4 and 5 to determine the IC50 values (n = 3, mean ± SEM).

Fig. 3 in Synthesis of bilocularin A carbamate derivatives and their evaluation as leucine transport inhibitors in prostate cancer cells

Fig. 3. ORTEP of bilocularin A carbamate analogue 7; Hydrogen atoms, EtOH and H2O molecules are omitted for clarity.

Fig. 1. Derivatisation reaction conditions for bilocularin A in Synthesis of bilocularin A carbamate derivatives and their evaluation as leucine transport inhibitors in prostate cancer cells

Fig. 1. Derivatisation reaction conditions for bilocularin A (1) and the resulting semi-synthetic carbamate library (2–9).

Resveratrol-Leucine Metabolite Synergy in Pre-diabetes

ClinicalTrials.gov study NCT01593605. IPD Sharing: Not stated. Countries: 1. Publications: 8.

Calorie Restriction With Leucine Supplementation

ClinicalTrials.gov study NCT01757340. IPD Sharing: Not stated. Countries: 1. Publications: 2.

Role of Leucine in the Regulation of Human Myofibrillar Protein Synthesis at Rest and Following Resistance Exercise

ClinicalTrials.gov study NCT01492010. IPD Sharing: Not stated. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →

Leucine Requirement in Adult Men and Women

ClinicalTrials.gov study NCT05394155. IPD Sharing: NO. Countries: 1. Publications: 1.

Casein Protein and Leucine Supplementation in Chronic Obstructive Pulmonary Disease (COPD)

ClinicalTrials.gov study NCT01734473. IPD Sharing: Not stated. Countries: 1. Publications: 2.

Study to Assess the Effect of Leucine Along With Resistance Exercise on Muscle Strength and Quality of Life in Elders

ClinicalTrials.gov study NCT00929929. IPD Sharing: Not stated. Countries: 1. Publications: 1.

Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic Fibrosis

ClinicalTrials.gov study NCT01172301. IPD Sharing: Not stated. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →

A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)

ClinicalTrials.gov study NCT06673056. IPD Sharing: NO. Countries: 6. Publications: 0.

Resistance Exercise Training and Amino Acid Leucine Supplementation in Frail Elderly Women

ClinicalTrials.gov study NCT01922167. IPD Sharing: Not stated. Countries: 1. Publications: 2.